Literature DB >> 21259329

Projection neurons from the central nucleus of the amygdala to the nucleus pontis oralis.

Simon J Fung1, Mingchu Xi, Jianhua Zhang, Pablo Torterolo, Sharon Sampogna, Francisco R Morales, Michael H Chase.   

Abstract

The present retrograde labeling study was designed to determine the presence and pattern of projections from individual subdivisions of the central nucleus of the amygdala (CNA) to the nucleus pontis oralis (NPO), which is a critical brainstem site involved in the generation and maintenance of active (REM) sleep. Projections from the CNA were labeled with the retrograde tracer cholera toxin B-subunit (CTB), which was injected, unilaterally, via microiontophoresis, into the NPO. Sections of the amygdala were immunostained in order to identify CTB-labeled CNA neurons and CNA neurons that contained CTB plus the vesicular glutamate transporter 2 (VGLUT2), which is a marker for glutamatergic neurons. Histological analyses revealed that retrogradely labeled neurons that project to the NPO were localized, ipsilaterally, within the medial, lateral, and capsular subdivisions of the CNA. In addition, a substantial proportion (24%) of all retrogradely labeled CNA neurons also exhibited VGLUT2 immunoreactivity. The present study demonstrates that glutamatergic neurons, which are present within various subdivisions of the CNA, project directly to the NPO. These data lend credence to the hypothesis that NPO neurons that are involved in the control of active sleep are activated by glutamatergic projections from the amygdala.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21259329      PMCID: PMC3272774          DOI: 10.1002/jnr.22554

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  44 in total

1.  Developmental pattern of three vesicular glutamate transporters in the rat superior olivary complex.

Authors:  Peter Blaesse; Sascha Ehrhardt; Eckhard Friauf; Hans Gerd Nothwang
Journal:  Cell Tissue Res       Date:  2005-02-16       Impact factor: 5.249

2.  Functional neuroanatomy of human rapid-eye-movement sleep and dreaming.

Authors:  P Maquet; J Péters; J Aerts; G Delfiore; C Degueldre; A Luxen; G Franck
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

3.  REM sleep and amygdala.

Authors:  P Maquet; G Franck
Journal:  Mol Psychiatry       Date:  1997-05       Impact factor: 15.992

4.  Amygdaloid pathway to the trigeminal motor nucleus via the pontine reticular formation in the rat.

Authors:  Y Takeuchi; T Satoda; T Tashiro; R Matsushima; M Uemura-Sumi
Journal:  Brain Res Bull       Date:  1988-11       Impact factor: 4.077

5.  Co-localization of glutamate and tubulin in putative excitatory neurons of the hippocampus and amygdala: an immunohistochemical study using monoclonal antibodies.

Authors:  A J McDonald; A J Beitz; A A Larson; R Kuriyama; C Sellitto; J E Madl
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

6.  Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta.

Authors:  H E Day; E J Curran; S J Watson; H Akil
Journal:  J Comp Neurol       Date:  1999-10-11       Impact factor: 3.215

7.  Pontine acetylcholine release is regulated by muscarinic autoreceptors.

Authors:  M T Roth; M A Fleegal; R Lydic; H A Baghdoyan
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

8.  Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism.

Authors:  M C Xi; F R Morales; M H Chase
Journal:  J Neurophysiol       Date:  1999-10       Impact factor: 2.714

9.  Enhancement of the acoustic startle response by stimulation of an excitatory pathway from the central amygdala/basal nucleus of Meynert to the pontine reticular formation.

Authors:  M Koch; U Ebert
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdala.

Authors:  J M Calvo; K Simón-Arceo; R Fernández-Mas
Journal:  Neuroreport       Date:  1996-01-31       Impact factor: 1.837

View more
  7 in total

1.  Sleep duration varies as a function of glutamate and GABA in rat pontine reticular formation.

Authors:  Christopher J Watson; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

2.  Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity.

Authors:  Emi Hasegawa; Takashi Maejima; Takayuki Yoshida; Olivia A Masseck; Stefan Herlitze; Mitsuhiro Yoshioka; Takeshi Sakurai; Michihiro Mieda
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

3.  Regulation of dark period sleep by the Amygdala: A microinjection and optogenetics study.

Authors:  Laurie L Wellman; Gyorgy Lonart; Austin M Adkins; Larry D Sanford
Journal:  Brain Res       Date:  2022-02-04       Impact factor: 3.252

4.  Orexin gene transfer into the amygdala suppresses both spontaneous and emotion-induced cataplexy in orexin-knockout mice.

Authors:  Meng Liu; Carlos Blanco-Centurion; Roda Rani Konadhode; Liju Luan; Priyattam J Shiromani
Journal:  Eur J Neurosci       Date:  2016-02-03       Impact factor: 3.386

5.  Amygdala lesions reduce cataplexy in orexin knock-out mice.

Authors:  Christian R Burgess; Yo Oishi; Takatoshi Mochizuki; John H Peever; Thomas E Scammell
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

Review 6.  Narcolepsy: neural mechanisms of sleepiness and cataplexy.

Authors:  Christian R Burgess; Thomas E Scammell
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

7.  The amygdala modulates prepulse inhibition of the auditory startle reflex through excitatory inputs to the caudal pontine reticular nucleus.

Authors:  Jose Carlos Cano; Wanyun Huang; Karine Fénelon
Journal:  BMC Biol       Date:  2021-06-03       Impact factor: 7.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.